New Fortress Energy CEO Edens buys $1.67m in shares

New Fortress Energy CEO Edens buys $1.67m in shares

New Fortress Energy CEO Edens buys $1.67m in shares
Key Points Cisco took $9.3 billion of AI infrastructure orders from hyperscalers in fiscal 2026, including $4 billion in the fourth quarter alone. Management expects $7.5 billion of AI infrastructure revenue from hyperscalers in fiscal 2027, roughly a tenth of guided revenue. Fourth-quarter gross margin fell 210 basis points on a heavier hardware mix and…
Don’t get ready for the 2027 Met Gala yet. The Metropolitan Museum of Art had announced on July 31 that the spring 2027 Costume Institute exhibition and Met Gala would honor British designer John Galliano. But on Monday, it shared that both will no longer “proceed as planned.” The decision to re-theme was made in…
US treasury sells $70 billion of 5 year notes at a high yield of 4.393% !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}
Alternative investment management firm 26 North is relocating its New York City offices to LeFrak’s Midtown office tower at 40 West 57th Street, Commercial Observer has learned. The company has inked an 84,000-square-foot lease at the 36-story property, where it will occupy four full floors following its move from 600 Madison Avenue, according to landlord…
Key Points AI data centers are approaching copper’s physical limits, accelerating adoption of silicon photonics solutions. Coherent and Lumentum supply critical optical components powering next-generation AI infrastructure growth. Silicon photonics offers a big long-term opportunity, but both stocks remain higher-risk, cyclical investments. 10 stocks we like better than Coherent › Much of the AI conversation…
Key Points Shares of AbbVie (NYSE: ABBV) were bouncing along merrily for most of Thursday’s trading session, until news of a fresh demand from the White House quashed the rally. Initially, the market was cheered by better-than-expected quarterly results published by the company that morning. Ultimately AbbVie’s stock closed down slightly lower in price, roughly…